Literature DB >> 30024393

Impaired oscillometric arterial stiffness parameters in patients with coronary artery ectasia.

Alaa Quisi1, Gökhan Alıcı, Samir Allahverdiyev, Ömer Genç, Ahmet Oytun Baykan, Süleyman Özbiçer, Mevlüt Koç.   

Abstract

OBJECTIVE: The aim of this study was to investigate the oscillometric measurements of the elastic properties of the aorta in patients with isolated coronary artery ectasia (CAE).
METHODS: This study included 137 patients (92 men and 45 women; mean age: 60.8±11.7 years) who underwent coronary angiography to investigate ischemic heart disease. The patients were divided into 3 groups; the first group consisted of 51 patients with CAE, the second group comprised 36 patients with coronary artery disease (CAD), and the third group was made up of 50 patients with normal coronary arteries. Aortic stiffness (AS) measurements, including pulse wave velocity (PWV) and augmentation index (AIx), were measured using the oscillometric method.
RESULTS: The mean PWV was significantly higher in the CAE group compared with the CAD and control groups (9.1±2.3 vs. 8.2±1.3 and 8.0±1.6; p=0.008), whereas the median AIx was significantly lower in the CAE group compared with the CAD and control groups (10.0% [-3.0-63.0] vs. 15.5% [-2.0-57.0] and 21.5% [-1.0-45.0]; p=0.010). Multinomial logistic regression analysis demonstrated that gender, hypertension, highdensity lipoprotein cholesterol level, PWV, and AIx were independently associated with CAE.
CONCLUSION: The oscillometric elastic properties of the aorta, including PWV and AIx, are impaired in patients with CAE.

Entities:  

Mesh:

Year:  2018        PMID: 30024393     DOI: 10.5543/tkda.2018.18562

Source DB:  PubMed          Journal:  Turk Kardiyol Dern Ars        ISSN: 1016-5169


  1 in total

1.  Hypertension and coronary artery ectasia: a systematic review and meta-analysis study.

Authors:  Mostafa Bahremand; Ehsan Zereshki; Behzad Karami Matin; Mansour Rezaei; Hamidreza Omrani
Journal:  Clin Hypertens       Date:  2021-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.